Psychedelics and Racial Justice

Psychedelic-assisted therapies show promise for treating mental health disorders, but people of color and other marginalized groups have been largely excluded from clinical trials, leaving fundamental clinical issues unaddressed. A narrative review of relevant research on racial trauma, ethnic minority mental health, and psychedelic therapies suggests these treatments can advance recovery for people of color, while also highlighting potential harms. As many psychedelic therapy trials near completion and access expands, the paper argues for equitable research practices—including community-based participatory research and culturally informed design—to foster inclusion and culturally competent care.

Study at a glance

Abstract

Psychedelics are being studied for the treatment of numerous mental health disorders, as well as a means of bringing people together. Nonetheless, people of color and those with other marginalized identities have not been fully included. Studies and research on psychedelic-assisted therapies have largely excluded people of color, leaving out fundamental clinical issues for these populations. This paper provides a narrative review of relevant research on this topic, racial trauma, ethnic minority mental health, and how psychedelic therapies can advance recovery for people of color. It also discusses potential harms and steps needed to promote culturally inclusive access to care. Many psychedelic therapy trials are in their final stages and access is being expanded, making it important to consider equitable practices in research that can foster inclusion, such as community-based participatory research and culturally informed research design.